Подписаться
Allen J Duplantier
Allen J Duplantier
Principal Consultant, Latham BioPharm Group
Подтвержден адрес электронной почты в домене lathambiopharm.com
Название
Процитировано
Процитировано
Год
The human cathelicidin antimicrobial peptide LL-37 as a potential treatment for polymicrobial infected wounds
AJ Duplantier, ML van Hoek
Frontiers in immunology 4, 143, 2013
2862013
Biarylcarboxylic Acids and -amides:  Inhibition of Phosphodiesterase Type IV versus [3H]Rolipram Binding Activity and Their Relationship to Emetic Behavior in …
AJ Duplantier, MS Biggers, RJ Chambers, JB Cheng, K Cooper, ...
Journal of medicinal chemistry 39 (1), 120-125, 1996
1641996
Discovery, SAR, and Pharmacokinetics of a Novel 3-Hydroxyquinolin-2(1H)-one Series of Potent d-Amino Acid Oxidase (DAAO) Inhibitors
AJ Duplantier, SL Becker, MJ Bohanon, KA Borzilleri, BA Chrunyk, ...
Journal of medicinal chemistry 52 (11), 3576-3585, 2009
1302009
Catechol diethers as selective PDEIV inhibitors
AJ Duplantier, JF Eggler, A Marfat, H Masamune
US Patent 5,814,651, 1998
1011998
Discovery of 4-(5-Methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a Novel α7 Nicotinic Acetylcholine Receptor Agonist for the …
CJ O’Donnell, BN Rogers, BS Bronk, DK Bryce, JW Coe, KK Cook, ...
Journal of medicinal chemistry 53 (3), 1222-1237, 2010
972010
Nicotinamide derivatives
A Marfat, RJ Chambers, JW Watson, JB Cheng, AJ Duplantier, ...
US Patent 6,380,218, 2002
842002
Mitigating the impact of antibacterial drug resistance through host-directed therapies: current progress, outlook, and challenges
CY Chiang, I Uzoma, RT Moore, M Gilbert, AJ Duplantier, RG Panchal
MBio 9 (1), 10.1128/mbio. 01932-17, 2018
722018
Discovering drugs for the treatment of Ebola virus
SL Bixler, AJ Duplantier, S Bavari
Current Treatment Options in Infectious Diseases 9, 299-317, 2017
712017
Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE …
AJ Duplantier, MA Dombroski, C Subramanyam, AM Beaulieu, SP Chang, ...
Bioorganic & medicinal chemistry letters 21 (12), 3708-3711, 2011
702011
Triple asymmetric synthesis for fragment assembly: validity of approximate multiplicativity of the three diastereofacial selectivities
AJ Duplantier, MH Nantz, JC Roberts, RP Short, P Somfai, S Masamune
Tetrahedron letters 30 (52), 7357-7360, 1989
671989
Pulmonary eosinophilia in a murine model of allergic inflammation is attenuated by small molecule α4β1 antagonists
E Kudlacz, C Whitney, C Andresen, A Duplantier, G Beckius, L Chupak, ...
Journal of Pharmacology and Experimental Therapeutics 301 (2), 747-752, 2002
622002
Triazolo-pyridines anti-inflammatory compounds
KF McClure, MA Letavic, MA Dombroski, AJ Duplantier, ER Laird
US Patent 6,696,464, 2004
602004
Recent successes in therapeutics for Ebola virus disease: no time for complacency
PL Iversen, CD Kane, X Zeng, RG Panchal, TK Warren, SR Radoshitzky, ...
The Lancet Infectious diseases 20 (9), e231-e237, 2020
522020
Pimaricin. Stereochemistry and synthesis of its aglycon (pimarolide) methyl ester
AJ Duplantier, S Masamune
Journal of the American Chemical Society 112 (19), 7079-7081, 1990
511990
Synthesis and in vitro profile of a novel series of catechol benzimidazoles. The discovery of potent, selective phosphodiesterase type IV inhibitors with greatly attenuated …
JB Cheng, K Cooper, AJ Duplantier, JF Eggler, KG Kraus, SC Marshall, ...
Bioorganic & Medicinal Chemistry Letters 5 (17), 1969-1972, 1995
501995
7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as Novel Inhibitors of Human Eosinophil Phosphodiesterase
AJ Duplantier, CJ Andresen, JB Cheng, VL Cohan, C Decker, ...
Journal of medicinal chemistry 41 (13), 2268-2277, 1998
471998
1-[(1-Methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 Positive Allosteric Modulators for the Treatment of Psychosis
L Zhang, MA Brodney, J Candler, AC Doran, AJ Duplantier, IV Efremov, ...
Journal of medicinal chemistry 54 (6), 1724-1739, 2011
432011
Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain
CA Strick, C Li, L Scott, B Harvey, M Hajós, SJ Steyn, MA Piotrowski, ...
Neuropharmacology 61 (5-6), 1001-1015, 2011
422011
Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
AJ Duplantier, LS Chupak, AJ Milici, WF Lau
US Patent 6,668,527, 2003
412003
Benzimidazolyl compounds
I Efremov, BN Rogers, AJ Duplantier, L Zhang, Q Zhang, NS Maklad, ...
US Patent App. 11/780,579, 2008
402008
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20